CardioNova goes on air of Radio of Russia to tell about AHRO-001

On April 11, at 19:30, the guest of Larisa Katysheva at the program “Tomorrow in the world”, going on air of Radio of Russia is Andrey Boldyrev, CEO of a Russian innovative biotech company CardioNova.

Andrey Boldyrev will talk about cardiovascular diseases, existing therapy standards and will address in detail the peculiarities and advantages of the drug designated for treatment of dislipidemy and preventive treatment of atherosclerosis, that is being developed by CardioNova.

Andrey will also answer the presenter’s question on peculiarities of development of innovative biotech companies in Russia and support they get from the existing


Anna Zelenkova,
PR director with Maxwell Biotech Group;
Tel.: +7 (495) 411-6992
E-mail: zelenkova@maxwellbiotech.ru

Search form